Little Journey

Primary contact
Health Foundry
Royal Street
SE1 7LL London
United Kingdom
Health Foundry
Royal Street
SE1 7LL London
United Kingdom
Sections Pediatric Care
Funding π°
Total Β£4M
Select investors Octopus Ventures, Mercia Asset Management, Calm/Storm Ventures, NHS Innovation Accelerator
Key people π§βπ€βπ§
- Dr Chris Evans - Co-founder & CEO
- Sophie Copley - Co-founder & CPO
- Nicolaus Henke - Chairman
- Azim Palmer - CTO
Highlights β
- Solving a problem: It is currently reported that about 75% of children will experience significant anxiety before a procedure. As a result, they often need sedative medication for the procedure to go ahead.
- It works: According to Little Journey's own research, its app can reduce anxiety by 32%, recovery time by 30%, and on-the-day cancellations by 42%.
- Also works for clinical trials: It is estimated that 25-40% of paediatric clinical trials fail to establish the right data to determine the safety and effectiveness of the treatment - and that's largely because of the anxiety and stress placed on children that results in dropouts. By using the app, research staff and CROs can configure content relevant to the trial and monitor progress through the management platform, while benefitting from improved recruitment, better adherence, a better patient experience, reduced withdrawals and faster trial delivery. π
Awards & Recognitions π
Quotes π¬
“
Chris, Sophie and the Little Journey team have developed a platform that not only has a hugely positive impact on the kids it's built to help but reduces costs for hospitals delivering paediatric care and smooth the creation of new, better treatments for children.
— Joe Stringer, Partner at Octopus Ventures π
Last update: April 26, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more